查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2059043

兒童安全藥品包裝市場預測至2034年－按包裝類型、材料類型、藥品類型、最終用戶和地區分類的全球分析

Child-Resistant Pharmaceutical Packaging Market Forecasts to 2034 - Global Analysis By Packaging Type, Material Type, Drug Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球兒童安全藥品包裝市場規模將達到 310 億美元，並在預測期內以 7.6% 的複合年成長率成長，到 2034 年將達到 560 億美元。

兒童安全藥品包裝是指專門設計的包裝解決方案，旨在防止五歲以下兒童接觸可能有害的藥物，同時方便成人取用。這些系統採用機械屏障，需要一定的靈巧度才能打開，例如按壓旋轉式瓶蓋、剝離式泡殼包裝和擠壓旋轉式裝置。製藥企業、合約包裝公司和醫療保健機構正在採用這些包裝，以符合安全法規、減少意外中毒事件，並滿足全球市場的產品責任要求。

嚴格的中毒預防條例

嚴格的中毒預防法規顯著提升了全球市場對兒童安全包裝的需求。美國《中毒預防包裝方法》強制多種處方藥和非處方藥使用兒童安全瓶蓋。歐洲和亞洲的監管機構也推出了類似的規定，以減少兒童中毒事件的發生。這些法規的執行包括合格評定、認證審核以及對不合規產品的處罰。製藥公司面臨因包裝相關事故而承擔重大法律責任的風險。這些監管和法律壓力使得兒童安全包裝不再只是一種可選的安全功能，而是成為進入市場的強制性要求。

老年人無障礙環境面臨的挑戰

老年人面臨的挑戰持續阻礙兒童安全包裝解決方案的最佳設計和應用。對於行動不便、手部靈活性和力量不足的老年人和關節炎患者而言，能夠有效防止兒童接觸的包裝機制往往難以使用。隨著人口老化，手部功能受限的用藥者人數不斷增加。如果患者無法打開包裝或將藥物轉移到非標準儲存容器中，則可能導致用藥依從性下降。在確保兒童安全和兼顧老年人友善性的同時，需要採用創新的工程方法，這會增加開發複雜性和製造成本。這些無障礙限制縮小了設計選擇範圍，並在使用者體驗方面造成了妥協。

智慧、互聯且合規的包裝

智慧互聯的合規包裝為兒童安全包裝供應商提供了一個重要的機遇，使其能夠整合數位化功能，從而提升安全性並提高用藥依從性。支援NFC功能的瓶蓋可以追蹤竄改記錄，並將用藥依從性資料傳送給醫療專業人員。電子鎖定機制為受監管藥物提供可設定的存取控制。互聯包裝可以通知看護者藥物洩漏或未經授權的存取試驗。這些智慧功能同時解決了兒童安全和成人用藥依從性的挑戰。隨著數位健康生態系統的成熟，互聯兒童安全包裝有望在受監管的藥品市場中佔據高階地位。

非專利包裝的商品化

非專利包裝的商品化對品牌兒童安全包裝製造商構成了重大的競爭威脅。當創新密封機制的專利到期時，低成本製造商開始模仿其設計並以更低的價格出售。面臨成本壓力的製藥公司可能會轉向非專利包裝供應商以維持利潤率。標準化的測試規程使得企業更容易在受監管的供應商之間轉換。大型批發商和連鎖藥局集中藥品採購能力加劇了價格競爭。這些商品化壓力降低了推動創新的包裝製造商的利潤率，並削弱了其持續投資研發的獎勵。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對兒童安全包裝產生了雙重影響：一方面，藥品需求激增；另一方面，供應鏈也受到衝擊。慢性病和精神類藥物處方量的增加擴大了目標市場規模。然而，包裝材料短缺和物流限制導致生產和交付延遲。疫情也加速了人們對宅配模式的關注，在這種模式下，運輸過程中包裝的完整性至關重要。疫情後，藥品消費量的持續成長和成熟的線上藥局分銷管道繼續支撐著對符合規範的藥品包裝的強勁需求。

在預測期內，單劑量包裝細分市場預計將佔據最大佔有率。

在預測期內，單劑量包裝預計將佔據最大的市場佔有率，這主要得益於其在醫院和長期護理機構的廣泛應用，因為在這些機構中，最大限度地減少用藥錯誤至關重要。單劑量製劑透過為每劑藥物提供獨立包裝，減少了配藥錯誤，並提高了庫存追蹤的準確性。醫療機構對藥物可追溯性的監管要求也推動了單劑量包裝的發展。慢性病管理用藥依從性支援包的成長進一步刺激了零售藥局的需求。隨著醫療保健系統將患者安全和用藥依從性放在首位，預計單劑量包裝將繼續保持其市場主導地位。

在預測期內，塑膠產業預計將呈現最高的複合年成長率。

在預測期內，塑膠領域預計將呈現最高的成長率，這主要得益於材料的多功能性、成本效益以及兒童安全瓶蓋設計的持續創新。塑膠材料具有優異的可塑性，能夠製造符合監管測試要求的複雜鎖定機構。與玻璃製品相比，塑膠的輕質特性降低了運輸成本。可回收塑膠和生物基塑膠的進步在不影響安全性能的前提下，解決了永續性問題。塑膠在醫藥應用整體泡殼包裝、瓶子和瓶蓋）的廣泛應用，確保了隨著全球藥品出貨量的持續成長，塑膠領域的持續發展也將得到保障。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於其嚴格的監管要求和全球最高的人均藥品消費量。美國全面執行《中毒預防包裝方法》，涵蓋所有藥品類別，推動了區域需求。總部位於該地區的領先藥品包裝公司正在引領創新並制定全球標準。高昂的醫療費用支出和處方藥的廣泛使用催生了龐大的包裝需求。此外，活躍的產品責任訴訟環境也促使製藥公司持續投資，以確保嚴格遵守。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興市場藥品生產能力的擴張和法規結構的強化。印度和中國等國是全球學名藥的主要供應國，這些藥品需要符合規定的出口包裝。人口老化和醫療保健的不斷擴展推動了國內藥品消費量的成長，從而提振了本地需求。各國政府為提升藥品品質標準所做的努力與國際上對兒童安全包裝的要求一致。隨著該地區逐漸成為藥品生產中心，兒童安全包裝正日益成為一項重要的合規基礎設施。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球兒童安全藥品包裝市場：依包裝類型分類

  • 吸塑包裝
    • 推入式吸塑包裝
    • 剝離式吸塑包裝
  • 瓶子和容器
    • 塑膠瓶
    • 玻璃瓶
  • 蓋子
    • 按壓旋轉式瓶蓋
    • 擠壓並旋轉閉合
    • 對齊箭頭閉合
  • 小袋和小袋
  • 單劑量包裝
  • 條狀包裝
  • 紙箱和二級包裝

第6章 全球兒童安全藥品包裝市場：依材料類型分類

  • 塑膠
  • 紙張和紙板
  • 玻璃
  • 鋁箔
  • 複合材料

第7章 全球兒童安全藥品包裝市場：依藥品類型分類

  • 處方藥
  • 非處方藥
  • 管制物質
  • 液體
  • 固態劑型

第8章 全球兒童安全藥品包裝市場：依最終用戶分類

  • 製藥公司
  • 合約包裝公司
  • 醫院和診所
  • 零售藥房
  • 網路藥房

第9章 全球兒童安全藥品包裝市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Amcor plc
  • Berry Global Inc.
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • AptarGroup, Inc.
  • Constantia Flexibles Group GmbH
  • SGD Pharma
  • Bormioli Pharma SpA
  • Nolato AB
  • Schott AG
  • Comar LLC
  • Origin Pharma Packaging
  • Bilcare Limited
  • Rpc Group Plc
  • Owen Mumford Ltd.
  • Tekni-Plex, Inc.
  • Alpha Packaging
Product Code: SMRC36669

According to Stratistics MRC, the Global Child-Resistant Pharmaceutical Packaging Market is accounted for $31.0 billion in 2026 and is expected to reach $56.0 billion by 2034 growing at a CAGR of 7.6% during the forecast period. Child-resistant pharmaceutical packaging refers to specialized packaging solutions designed to prevent children under five years of age from accessing potentially harmful medications while remaining accessible to adults. These systems incorporate mechanical barriers such as push-and-turn closures, peel-push blister packs, and squeeze-and-turn mechanisms that require coordinated dexterity to open. Pharmaceutical manufacturers, contract packaging organizations, and healthcare providers deploy them to comply with safety regulations, reduce accidental poisoning incidents, and meet product liability requirements across global markets.

Market Dynamics:

Driver:

Stringent poison prevention regulations

Stringent poison prevention regulations are driving substantial demand for child-resistant pharmaceutical packaging across global markets. The United States Poison Prevention Packaging Act mandates child-resistant closures for numerous prescription and over-the-counter medications. European and Asian regulatory bodies are implementing similar requirements to reduce the incidence of pediatric poisoning. Regulatory enforcement includes compliance testing, certification audits, and penalties for non-conforming products. Pharmaceutical companies face significant liability exposure from packaging-related incidents. These regulatory and legal pressures establish child-resistant packaging as a non-negotiable requirement for market access, rather than an optional safety feature.

Restraint:

Senior adult accessibility challenges

Senior adult accessibility challenges continue to restrain optimal design and adoption of child-resistant pharmaceutical packaging solutions. Packaging mechanisms that effectively deter children often frustrate elderly and arthritic adults who struggle with required dexterity and strength. The aging global population increases the number of medication users with impaired hand function. Poor accessibility leads to medication non-compliance when patients cannot open containers or transfer contents to non-compliant storage. Balancing child safety with senior-friendly design requires innovative engineering approaches that add development complexity and manufacturing cost. These accessibility constraints limit design options and create user experience trade-offs.

Opportunity:

Smart connected compliance packaging

Smart connected compliance packaging represents a significant opportunity for child-resistant pharmaceutical packaging providers to integrate digital capabilities that enhance both safety and medication adherence. NFC-enabled caps can track opening events and transmit compliance data to healthcare providers. Electronic locking mechanisms provide configurable access control for controlled substances. Connected packaging can alert caregivers to missed doses or unauthorized access attempts. These smart features address both child safety and adult adherence challenges simultaneously. As digital health ecosystems mature, connected child-resistant packaging is expected to command premium positioning in regulated pharmaceutical markets.

Threat:

Generic packaging commoditization

Generic packaging commoditization poses a significant competitive threat to branded child-resistant pharmaceutical packaging manufacturers. Once patents expire on innovative closure mechanisms, lower-cost manufacturers replicate designs at reduced prices. Pharmaceutical companies under cost pressure may switch to generic packaging suppliers to maintain margins. Standardized testing protocols enable easier substitution between compliant suppliers. The concentration of pharmaceutical purchasing power among large distributors and pharmacy chains intensifies price competition. These commoditization pressures erode margins for innovation-leading packaging companies and reduce incentives for continued research and development investment.

Covid-19 Impact:

The COVID-19 pandemic created divergent impacts on child-resistant pharmaceutical packaging by increasing medication demand while disrupting supply chains. Higher prescription volumes for chronic conditions and mental health medications expanded the addressable market size. However, packaging material shortages and logistics constraints delayed production and delivery. The pandemic also accelerated interest in home delivery models that require robust packaging integrity during shipping. Post-pandemic, sustained higher medication consumption levels and established e-pharmacy distribution channels continue to support strong demand for compliant pharmaceutical packaging.

The unit dose packaging segment is expected to be the largest during the forecast period

The unit dose packaging segment is expected to account for the largest market share during the forecast period, due to widespread adoption in hospital and long-term care settings where medication errors must be minimized. Unit dose formats provide individual packaging for each administration occasion, reducing dispensing errors and improving inventory tracking. Regulatory requirements for medication traceability in healthcare facilities favor unit dose approaches. The growth of adherence packaging for chronic disease management creates additional demand in retail pharmacy settings. As healthcare systems prioritize patient safety and medication compliance, unit dose packaging is expected to maintain its dominant market position.

The plastic segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the plastic segment is predicted to witness the highest growth rate, driven by material versatility, cost efficiency, and continuous innovation in child-resistant closure design. Plastic formulations offer excellent moldability for complex locking mechanisms that meet regulatory testing requirements. Lightweight properties reduce shipping costs compared to glass alternatives. Advances in recyclable and bio-based plastics address sustainability concerns without compromising safety performance. The dominance of plastic in blister packaging, bottles, and closures across pharmaceutical applications ensures sustained growth as global medication volumes continue to expand.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to stringent regulatory requirements and the highest per-capita pharmaceutical consumption globally. The United States leads regional demand with comprehensive Poison Prevention Packaging Act enforcement across all medication categories. Major pharmaceutical packaging companies headquartered in the region drive innovation and establish global standards. High healthcare spending and extensive prescription drug use create substantial packaging volume requirements. Additionally, an active litigation environment regarding product liability sustains rigorous compliance investment by pharmaceutical manufacturers.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding pharmaceutical manufacturing capacity and strengthening regulatory frameworks across emerging markets. Countries such as India and China are major global suppliers of generic medications requiring compliant export packaging. Growing domestic pharmaceutical consumption driven by aging populations and healthcare expansion, increases local demand. Government initiatives promoting pharmaceutical quality standards align with international child-resistant packaging requirements. The region's emergence as a pharmaceutical manufacturing hub positions child-resistant packaging as essential compliance infrastructure.

Key players in the market

Some of the key players in Child-Resistant Pharmaceutical Packaging Market include Amcor plc, Berry Global Inc., West Pharmaceutical Services, Inc., Gerresheimer AG, AptarGroup, Inc., Constantia Flexibles Group GmbH, SGD Pharma, Bormioli Pharma S.p.A., Nolato AB, Schott AG, Comar LLC, Origin Pharma Packaging, Bilcare Limited, Rpc Group Plc, Owen Mumford Ltd., Tekni-Plex, Inc., and Alpha Packaging.

Key Developments:

In May 2026, Amcor plc launched a next-generation child-resistant closure with senior-friendly ergonomic design, meeting enhanced accessibility standards while maintaining compliance with poison prevention regulations.

In April 2026, West Pharmaceutical Services, Inc. expanded its unit dose packaging portfolio with smart blister cards featuring integrated NFC tags for medication adherence tracking and pediatric access alerts.

In March 2026, Gerresheimer AG introduced sustainable glass pharmaceutical bottles with innovative child-resistant closures using bio-based plastic components for eco-conscious medication packaging.

In February 2026, AptarGroup, Inc. unveiled a dual-lock child-resistant closure system for liquid medications, combining squeeze-and-turn mechanisms with audible confirmation for enhanced safety verification.

Packaging Types Covered:

  • Blister Packaging
  • Bottles & Containers
  • Closures & Caps
  • Pouches & Sachets
  • Unit Dose Packaging
  • Strip Packaging
  • Cartons & Secondary Packaging

Material Types Covered:

  • Plastic
  • Paper & Paperboard
  • Glass
  • Aluminum Foil
  • Composite Materials

Drug Types Covered:

  • Prescription Drugs
  • Over-the-Counter Drugs
  • Controlled Substances
  • Liquid Medications
  • Solid Dosage Forms

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Packaging Organizations
  • Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Child-Resistant Pharmaceutical Packaging Market, By Packaging Type

  • 5.1 Blister Packaging
    • 5.1.1 Push-Through Blister Packs
    • 5.1.2 Peel-Push Blister Packs
  • 5.2 Bottles & Containers
    • 5.2.1 Plastic Bottles
    • 5.2.2 Glass Bottles
  • 5.3 Closures & Caps
    • 5.3.1 Push-and-Turn Closures
    • 5.3.2 Squeeze-and-Turn Closures
    • 5.3.3 Align-Arrow Closures
  • 5.4 Pouches & Sachets
  • 5.5 Unit Dose Packaging
  • 5.6 Strip Packaging
  • 5.7 Cartons & Secondary Packaging

6 Global Child-Resistant Pharmaceutical Packaging Market, By Material Type

  • 6.1 Plastic
  • 6.2 Paper & Paperboard
  • 6.3 Glass
  • 6.4 Aluminum Foil
  • 6.5 Composite Materials

7 Global Child-Resistant Pharmaceutical Packaging Market, By Drug Type

  • 7.1 Prescription Drugs
  • 7.2 Over-the-Counter Drugs
  • 7.3 Controlled Substances
  • 7.4 Liquid Medications
  • 7.5 Solid Dosage Forms

8 Global Child-Resistant Pharmaceutical Packaging Market, By End User

  • 8.1 Pharmaceutical Manufacturers
  • 8.2 Contract Packaging Organizations
  • 8.3 Hospitals & Clinics
  • 8.4 Retail Pharmacies
  • 8.5 Online Pharmacies

9 Global Child-Resistant Pharmaceutical Packaging Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Amcor plc
  • 12.2 Berry Global Inc.
  • 12.3 West Pharmaceutical Services, Inc.
  • 12.4 Gerresheimer AG
  • 12.5 AptarGroup, Inc.
  • 12.6 Constantia Flexibles Group GmbH
  • 12.7 SGD Pharma
  • 12.8 Bormioli Pharma S.p.A.
  • 12.9 Nolato AB
  • 12.10 Schott AG
  • 12.11 Comar LLC
  • 12.12 Origin Pharma Packaging
  • 12.13 Bilcare Limited
  • 12.14 Rpc Group Plc
  • 12.15 Owen Mumford Ltd.
  • 12.16 Tekni-Plex, Inc.
  • 12.17 Alpha Packaging

List of Tables

  • Table 1 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Packaging Type (2023-2034) ($MN)
  • Table 3 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Blister Packaging (2023-2034) ($MN)
  • Table 4 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Push-Through Blister Packs (2023-2034) ($MN)
  • Table 5 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Peel-Push Blister Packs (2023-2034) ($MN)
  • Table 6 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Bottles & Containers (2023-2034) ($MN)
  • Table 7 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Plastic Bottles (2023-2034) ($MN)
  • Table 8 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Glass Bottles (2023-2034) ($MN)
  • Table 9 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Closures & Caps (2023-2034) ($MN)
  • Table 10 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Push-and-Turn Closures (2023-2034) ($MN)
  • Table 11 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Squeeze-and-Turn Closures (2023-2034) ($MN)
  • Table 12 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Align-Arrow Closures (2023-2034) ($MN)
  • Table 13 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Pouches & Sachets (2023-2034) ($MN)
  • Table 14 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Unit Dose Packaging (2023-2034) ($MN)
  • Table 15 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Strip Packaging (2023-2034) ($MN)
  • Table 16 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Cartons & Secondary Packaging (2023-2034) ($MN)
  • Table 17 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Material Type (2023-2034) ($MN)
  • Table 18 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Plastic (2023-2034) ($MN)
  • Table 19 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Paper & Paperboard (2023-2034) ($MN)
  • Table 20 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Glass (2023-2034) ($MN)
  • Table 21 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Aluminum Foil (2023-2034) ($MN)
  • Table 22 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Composite Materials (2023-2034) ($MN)
  • Table 23 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Drug Type (2023-2034) ($MN)
  • Table 24 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Prescription Drugs (2023-2034) ($MN)
  • Table 25 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Over-the-Counter Drugs (2023-2034) ($MN)
  • Table 26 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Controlled Substances (2023-2034) ($MN)
  • Table 27 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Liquid Medications (2023-2034) ($MN)
  • Table 28 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Solid Dosage Forms (2023-2034) ($MN)
  • Table 29 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Pharmaceutical Manufacturers (2023-2034) ($MN)
  • Table 31 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Contract Packaging Organizations (2023-2034) ($MN)
  • Table 32 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 33 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 34 Global Child-Resistant Pharmaceutical Packaging Market Outlook, By Online Pharmacies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.